About Index Trending news
Analyze
Top 50 Pricing
Jounce Therapeutics

Jounce Therapeutics

Work at Jounce Therapeutics? Add yourself to this profile

Jounce Therapeutics

Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series B)
$56,000,000
Redmile Group, Foresite Capital, Wellington Management, +5
Employees

Team size

50+
Locations
HQ
$56,000,000 Venture capital (Series B)
VentureWire

The Daily Startup: Jounce Therapeutics Raises $56M as Immunotherapy Stays Hot

Funding